Ambiq Micro Reports Strong Q4 Sales Beat and Significant Margin Expansion, Guides for Continued Growth
Summary
Ambiq Micro announced fourth quarter and full year 2025 financial results, reporting Q4 net sales that exceeded guidance and substantial gross margin expansion, alongside positive sequential growth guidance for Q1 2026.
Key Events
-
Strong Q4 2025 Performance
Net sales of $20.7 million exceeded guidance and marked the highest quarterly net sales of 2025, showing 14.2% sequential growth from Q3 2025.
-
Significant Gross Margin Expansion
GAAP gross margin for Q4 2025 reached 42.7%, a substantial increase from 24.8% in Q4 2024, with full year 2025 gross profit being the highest in company history.
-
Positive Q1 2026 Outlook
The company forecasts Q1 2026 net sales between $21.0 million and $22.0 million, indicating continued sequential growth.
-
Full Year Sales Decline
Despite quarterly improvements, full year 2025 net sales decreased by 4.7% to $72.5 million compared to $76.067 million in 2024.
Analysis
This 8-K filing officially discloses Ambiq Micro's Q4 and full year 2025 financial results, which were previously reported by news wires. The company demonstrated strong operational execution with Q4 net sales of $20.7 million surpassing guidance and marking the highest quarterly sales of 2025, driven by accelerated customer demand. A key highlight is the significant GAAP gross margin expansion to 42.7% in Q4 2025, up from 24.8% in the prior year, with full year gross profit reaching a company record. While full year sales saw a slight decline, the sequential growth in every quarter of 2025 and the positive Q1 2026 net sales guidance of $21.0 million to $22.0 million indicate growing momentum, particularly in advanced edge AI adoption. Investors should monitor the company's ability to sustain this growth and continue improving profitability as it scales its higher-value Apollo platforms.
At the time of this filing, AMBQ was trading at $29.50 on NYSE in the Manufacturing sector, with a market capitalization of approximately $588.2M. The 52-week trading range was $22.12 to $51.76. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.